Mid-Year Report — PODESTA GROUP, INC. for GENZYME (2007)

Firm

PODESTA GROUP, INC.

Client

GENZYME

Income

$80,000

Expenses

—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN	N/A
RANDALL GERARD	N/A
COURTNEY HAGEN	N/A
ANDREW KAUDERS	SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA	N/A
SETH NICHOLS	—
ANTHONY PODESTA	N/A
ANNE MARIE POLAK	LEG CORRESPONDENT FOR CONG. MIKE FERGUSON

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: S. 3 (110th), H.Con.Res. 99 (110th), H.R. 4 (110th), S.Con.Res. 21 (110th), H.R. 2606 (110th), S. 1376 (110th), H.R. 3162 (110th)

Pharmacy PHA

S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN	N/A
RANDALL GERARD	N/A
COURTNEY HAGEN	N/A
ANDREW KAUDERS	SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA	N/A
SETH NICHOLS	—
ANTHONY PODESTA	N/A
ANNE MARIE POLAK	LEG CORRESPONDENT FOR CONG. MIKE FERGUSON

Contacted: Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1156 (110th), H.R. 1 (110th), H.R. 1561 (110th), H.R. 2900 (110th), S. 623 (110th), S. 467 (110th), S. 1024 (110th), S. 1695 (110th), S.Con.Res. 21 (110th), H.R. 1956 (110th), S. 1505 (110th), S. 242 (110th), S. 484 (110th), S. 993 (110th), H.R. 1038 (110th), S. 1082 (110th), H.Con.Res. 99 (110th), S. 4 (110th), S. 596 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, process patents H R. 1908, Patent Reform Act of 2007, process patents

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN	N/A
RANDALL GERARD	N/A
COURTNEY HAGEN	N/A
ANDREW KAUDERS	SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA	N/A
SETH NICHOLS	—
ANTHONY PODESTA	N/A
ANNE MARIE POLAK	LEG CORRESPONDENT FOR CONG. MIKE FERGUSON

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO)

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Budget/Appropriations BUD

S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN	N/A
RANDALL GERARD	N/A
COURTNEY HAGEN	N/A
ANDREW KAUDERS	SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA	N/A
SETH NICHOLS	—
ANTHONY PODESTA	N/A
ANNE MARIE POLAK	LEG CORRESPONDENT FOR CONG. MIKE FERGUSON

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3043 (110th), H.Con.Res. 99 (110th), S. 1710 (110th), S.Con.Res. 21 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.